Nuevas estrategias en el tratamiento del síndrome antifosfolípido

For years the mainstay of antiphospholipid syndrome treatment has been anticoagulation and antiplatelet therapy, but the autoimmune nature of the disease, and complications of these therapies, created the need to develop new therapeutic strategies. New therapeutic alternatives inhibit at different l...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ibáñez,Sebastián, Iruretagoyena,Mirentxu, Gutiérrez,Miguel A
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2013
Materias:	Antiphospholipid syndrome Hydroxychloroquine, Hydroxymethylglutaryl-CoA Reductase Inhibitors Therapies, investigational
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000800011
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872013000800011
record_format	dspace
spelling	oai:scielo:S0034-988720130008000112014-01-27Nuevas estrategias en el tratamiento del síndrome antifosfolípidoIbáñez,SebastiánIruretagoyena,MirentxuGutiérrez,Miguel A Antiphospholipid syndrome Hydroxychloroquine, Hydroxymethylglutaryl-CoA Reductase Inhibitors Therapies, investigational For years the mainstay of antiphospholipid syndrome treatment has been anticoagulation and antiplatelet therapy, but the autoimmune nature of the disease, and complications of these therapies, created the need to develop new therapeutic strategies. New therapeutic alternatives inhibit at different levels, the cascade of events leading to the pro-thrombotic state characteristic of the antiphospholipid syndrome. We conducted a literature review of these new treatments, focusing on the pathophysiological bases that support them and their possible clinical applications.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.8 20132013-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000800011es10.4067/S0034-98872013000800011
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Antiphospholipid syndrome Hydroxychloroquine, Hydroxymethylglutaryl-CoA Reductase Inhibitors Therapies, investigational
spellingShingle	Antiphospholipid syndrome Hydroxychloroquine, Hydroxymethylglutaryl-CoA Reductase Inhibitors Therapies, investigational Ibáñez,Sebastián Iruretagoyena,Mirentxu Gutiérrez,Miguel A Nuevas estrategias en el tratamiento del síndrome antifosfolípido
description	For years the mainstay of antiphospholipid syndrome treatment has been anticoagulation and antiplatelet therapy, but the autoimmune nature of the disease, and complications of these therapies, created the need to develop new therapeutic strategies. New therapeutic alternatives inhibit at different levels, the cascade of events leading to the pro-thrombotic state characteristic of the antiphospholipid syndrome. We conducted a literature review of these new treatments, focusing on the pathophysiological bases that support them and their possible clinical applications.
author	Ibáñez,Sebastián Iruretagoyena,Mirentxu Gutiérrez,Miguel A
author_facet	Ibáñez,Sebastián Iruretagoyena,Mirentxu Gutiérrez,Miguel A
author_sort	Ibáñez,Sebastián
title	Nuevas estrategias en el tratamiento del síndrome antifosfolípido
title_short	Nuevas estrategias en el tratamiento del síndrome antifosfolípido
title_full	Nuevas estrategias en el tratamiento del síndrome antifosfolípido
title_fullStr	Nuevas estrategias en el tratamiento del síndrome antifosfolípido
title_full_unstemmed	Nuevas estrategias en el tratamiento del síndrome antifosfolípido
title_sort	nuevas estrategias en el tratamiento del síndrome antifosfolípido
publisher	Sociedad Médica de Santiago
publishDate	2013
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000800011
work_keys_str_mv	AT ibanezsebastian nuevasestrategiaseneltratamientodelsindromeantifosfolipido AT iruretagoyenamirentxu nuevasestrategiaseneltratamientodelsindromeantifosfolipido AT gutierrezmiguela nuevasestrategiaseneltratamientodelsindromeantifosfolipido
_version_	1718436706233876480

Nuevas estrategias en el tratamiento del síndrome antifosfolípido

Ejemplares similares